opsoclonus myoclonus syndrome

(redirected from Opsoclonus Myoclonus)

opsoclonus myoclonus syndrome

A rare brain and eye disease characterized by abnormal muscle jerking, unsteady gait, poor speech, and abnormal eye movements. The disease is most often identified in children with recent viral infections or brain tumors. Synonym: dancing eyes-dancing feet syndrome; Kinsbourne syndrome
References in periodicals archive ?
Seoul National University Bundang Hospital (SNUBH) Case: Unexplained Opsoclonus Myoclonus Ataxia (Rapid involuntary eye movement and muscle twitch and body imbalance)
Kate was diagnosed with Opsoclonus Myoclonus Syndrome in 2017 and is currently undergoing treatment, including blood transfusions, every month.
Diagnostic and demographic details of the patients treated with plasmapheresis Diagnosis Number Mean age [+ or -] SD Sex of the (Female/ patients Male) GBS 60 52.5 [+ or -] 15.86 27/33 CIDP 4 49.3 [+ or -] 17 2/2 MG (prethymectomy) 9 41.1 [+ or -] 18.8 5/4 MC 14 51.6 [+ or -] 15.6 3/11 ADEM 1 28 0/1 Septic Encephalopathy 1 18 1/0 Polymyositis 1 51 0/1 OMS 1 49 0/1 GBS: Guillain Barre Syndrome, CIDP: Chronic Inflammatory Demyelinating Polyneuropathy, MG: Myasthenia Gravis, MC: Myasthenic Crisis, ADEM: Acute Disseminated Encephalomyelitis, OMS: Opsoclonus Myoclonus Syndrome Table 2.
On April 24th, 2013, Baby Jonathan "Tell" was diagnosed with Opsoclonus Myoclonus Ataxia Syndrome (OMS) at the young age of 20 months old.
Acthar Gel is an injectable drug that is approved for the treatment of exacerbations associated with multiple sclerosis, infantile spasms, opsoclonus myoclonus syndrome, and nephrotic syndrome.